JP2005532289A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005532289A5 JP2005532289A5 JP2003583385A JP2003583385A JP2005532289A5 JP 2005532289 A5 JP2005532289 A5 JP 2005532289A5 JP 2003583385 A JP2003583385 A JP 2003583385A JP 2003583385 A JP2003583385 A JP 2003583385A JP 2005532289 A5 JP2005532289 A5 JP 2005532289A5
- Authority
- JP
- Japan
- Prior art keywords
- polymer
- sustained release
- hydrophobic polymer
- hydrophobic
- hydrophilic polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001600 hydrophobic polymer Polymers 0.000 claims description 9
- 229920001477 hydrophilic polymer Polymers 0.000 claims description 7
- 238000013268 sustained release Methods 0.000 claims description 6
- 239000012730 sustained-release form Substances 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 4
- 238000000576 coating method Methods 0.000 claims description 4
- 239000007939 sustained release tablet Substances 0.000 claims 1
- 239000001856 Ethyl cellulose Substances 0.000 description 4
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 4
- 235000019325 ethyl cellulose Nutrition 0.000 description 4
- 229920001249 ethyl cellulose Polymers 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001761 ethyl methyl cellulose Substances 0.000 description 1
- 235000010944 ethyl methyl cellulose Nutrition 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/120,501 US7125563B2 (en) | 2002-04-12 | 2002-04-12 | Sustained release pharmaceutical preparations and methods for producing the same |
| PCT/US2003/009210 WO2003086364A1 (en) | 2002-04-12 | 2003-04-11 | Sustained release pharmaceutical prepartations and methods for producing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005532289A JP2005532289A (ja) | 2005-10-27 |
| JP2005532289A5 true JP2005532289A5 (enExample) | 2006-06-01 |
Family
ID=29214431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003583385A Pending JP2005532289A (ja) | 2002-04-12 | 2003-04-11 | 持続放出性医薬製剤及びその製造方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US7125563B2 (enExample) |
| EP (1) | EP1494653A1 (enExample) |
| JP (1) | JP2005532289A (enExample) |
| CN (1) | CN1655765A (enExample) |
| AU (1) | AU2003218397A1 (enExample) |
| CA (1) | CA2481667A1 (enExample) |
| HR (1) | HRP20040945A2 (enExample) |
| PL (1) | PL373328A1 (enExample) |
| RU (1) | RU2004133532A (enExample) |
| WO (1) | WO2003086364A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0203296D0 (en) | 2002-02-12 | 2002-03-27 | Glaxo Group Ltd | Novel composition |
| US8637512B2 (en) | 2002-07-29 | 2014-01-28 | Glaxo Group Limited | Formulations and method of treatment |
| ATE341312T1 (de) * | 2003-05-20 | 2006-10-15 | Ethypharm Sa | Orale pharmazeutische zusammensetzung mit verzögerter freisetzung |
| EP2112920B1 (en) | 2003-06-26 | 2018-07-25 | Intellipharmaceutics Corp. | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
| US8394409B2 (en) | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
| US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
| US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
| ATE536867T1 (de) | 2006-03-16 | 2011-12-15 | Tris Pharma Inc | Modifizierte freisetzungsformulierungen mit arznei-ion-austausch-harzkomplexen |
| WO2007112581A1 (en) | 2006-04-03 | 2007-10-11 | Isa Odidi | Controlled release delivery device comprising an organosol coat |
| US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
| EP2296634A1 (en) * | 2008-06-02 | 2011-03-23 | Dexcel Pharma Technologies Ltd. | Process for manufacture of a medicament with granulation and pan coating |
| ES2706880T3 (es) | 2010-02-22 | 2019-04-01 | Daiichi Sankyo Co Ltd | Preparación sólida de liberación sostenida para uso oral |
| TW201200165A (en) * | 2010-02-22 | 2012-01-01 | Daiichi Sankyo Co Ltd | Oral solid extended release dosage form |
| US8623409B1 (en) | 2010-10-20 | 2014-01-07 | Tris Pharma Inc. | Clonidine formulation |
| RU2665372C2 (ru) | 2012-09-03 | 2018-08-29 | Дайити Санкио Компани, Лимитед | Пероральная фармацевтическая композиция замедленного высвобождения, содержащая гидрохлорид гидроморфона |
| US11590228B1 (en) | 2015-09-08 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine compositions |
| US9949964B2 (en) * | 2016-09-07 | 2018-04-24 | Saniona A/S | Tesofensine compositions |
| US11590081B1 (en) | 2017-09-24 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine tablets |
| US12458592B1 (en) | 2017-09-24 | 2025-11-04 | Tris Pharma, Inc. | Extended release amphetamine tablets |
| US11918689B1 (en) | 2020-07-28 | 2024-03-05 | Tris Pharma Inc | Liquid clonidine extended release composition |
Family Cites Families (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4264573A (en) | 1979-05-21 | 1981-04-28 | Rowell Laboratories, Inc. | Pharmaceutical formulation for slow release via controlled surface erosion |
| US4252786A (en) * | 1979-11-16 | 1981-02-24 | E. R. Squibb & Sons, Inc. | Controlled release tablet |
| US4327725A (en) | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
| US4765989A (en) | 1983-05-11 | 1988-08-23 | Alza Corporation | Osmotic device for administering certain drugs |
| US4612008A (en) | 1983-05-11 | 1986-09-16 | Alza Corporation | Osmotic device with dual thermodynamic activity |
| US4783337A (en) | 1983-05-11 | 1988-11-08 | Alza Corporation | Osmotic system comprising plurality of members for dispensing drug |
| US4587117A (en) | 1983-06-06 | 1986-05-06 | Alza Corporation | Medical device for delivering drug to pH environments greater than 3.5 |
| US4503030A (en) | 1983-06-06 | 1985-03-05 | Alza Corporation | Device for delivering drug to certain pH environments |
| US4751071A (en) | 1983-12-01 | 1988-06-14 | Alza Corporation | Composition comprising salbutamol |
| US4777049A (en) | 1983-12-01 | 1988-10-11 | Alza Corporation | Constant release system with pulsed release |
| US4851229A (en) | 1983-12-01 | 1989-07-25 | Alza Corporation | Composition comprising a therapeutic agent and a modulating agent |
| US4695591A (en) * | 1985-03-29 | 1987-09-22 | Schering Corporation | Controlled release dosage forms comprising hydroxypropylmethylcellulose |
| IT1213080B (it) * | 1986-06-17 | 1989-12-07 | Recordati Chem Pharm | Sistemi terapeutico per la cessione controllata di farmaci. |
| US5254347A (en) | 1988-03-31 | 1993-10-19 | Tanabe Seiyaku Co., Ltd. | Controlled release pharmaceutical preparation and method for producing the same |
| US4996047A (en) * | 1988-11-02 | 1991-02-26 | Richardson-Vicks, Inc. | Sustained release drug-resin complexes |
| IL92966A (en) | 1989-01-12 | 1995-07-31 | Pfizer | Dispensing devices powered by hydrogel |
| US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| US5248516A (en) * | 1989-12-19 | 1993-09-28 | Fmc Corporation | Film-forming composition: method of producing same and use for coating pharmaceuticals and foods and the like |
| IE82916B1 (en) | 1990-11-02 | 2003-06-11 | Elan Corp Plc | Formulations and their use in the treatment of neurological diseases |
| US5075115A (en) * | 1990-04-02 | 1991-12-24 | Fmc Corporation | Process for polymerizing poly(lactic acid) |
| IE61651B1 (en) | 1990-07-04 | 1994-11-16 | Zambon Spa | Programmed release oral solid pharmaceutical dosage form |
| AU654991B2 (en) | 1990-12-20 | 1994-12-01 | Warner-Jenkinson Company, Inc. | Wet powder film-forming compositions |
| JPH04235914A (ja) * | 1991-01-18 | 1992-08-25 | Kyowa Hakko Kogyo Co Ltd | 徐放性製剤 |
| FI93924C (fi) * | 1991-09-17 | 1995-06-26 | Martti Lauri Antero Marvola | Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi |
| DK0542364T3 (da) * | 1991-11-13 | 1996-03-11 | Glaxo Canada | Anordning til reguleret frigivelse |
| US5681585A (en) | 1991-12-24 | 1997-10-28 | Euro-Celtique, S.A. | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
| US5543154A (en) | 1991-12-27 | 1996-08-06 | Merck & Co., Inc. | Controlled release nifedipine delivery device |
| JP2665858B2 (ja) * | 1992-05-30 | 1997-10-22 | 日本ヘキスト・マリオン・ルセル株式会社 | 持効性塩酸オキシブチニン製剤 |
| NZ260408A (en) | 1993-05-10 | 1996-05-28 | Euro Celtique Sa | Controlled release preparation comprising tramadol |
| CN1071570C (zh) | 1993-06-14 | 2001-09-26 | 詹森药业有限公司 | 阿司咪唑和假麻黄碱的缓释薄膜包衣片 |
| US5472714A (en) | 1993-09-08 | 1995-12-05 | Ciba-Geigy Corporation | Double-layered oxcarbazepine tablets |
| US5662933A (en) * | 1993-09-09 | 1997-09-02 | Edward Mendell Co., Inc. | Controlled release formulation (albuterol) |
| US5500227A (en) | 1993-11-23 | 1996-03-19 | Euro-Celtique, S.A. | Immediate release tablet cores of insoluble drugs having sustained-release coating |
| US6210714B1 (en) | 1993-11-23 | 2001-04-03 | Euro-Celtique S.A. | Immediate release tablet cores of acetaminophen having sustained-release coating |
| HU213407B (en) * | 1993-12-09 | 1997-06-30 | Egyt Gyogyszervegyeszeti Gyar | Process for producing tablet with diffusive-osmotic release |
| US5464633A (en) | 1994-05-24 | 1995-11-07 | Jagotec Ag | Pharmaceutical tablets releasing the active substance after a definite period of time |
| SE9402431D0 (sv) | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
| US6156343A (en) | 1994-12-27 | 2000-12-05 | Akzo Nobel N.V. | Controlled release preparation |
| IL116674A (en) | 1995-01-09 | 2003-05-29 | Mendell Co Inc Edward | Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof |
| US6124355A (en) | 1995-05-22 | 2000-09-26 | Guittard; George V. | Oxybutynin therapy |
| US5674895A (en) | 1995-05-22 | 1997-10-07 | Alza Corporation | Dosage form comprising oxybutynin |
| US6262115B1 (en) | 1995-05-22 | 2001-07-17 | Alza Coporation | Method for the management of incontinence |
| US5912268A (en) | 1995-05-22 | 1999-06-15 | Alza Corporation | Dosage form and method for treating incontinence |
| US5945124A (en) | 1995-07-05 | 1999-08-31 | Byk Gulden Chemische Fabrik Gmbh | Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole |
| SE9600072D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients II |
| US6245351B1 (en) | 1996-03-07 | 2001-06-12 | Takeda Chemical Industries, Ltd. | Controlled-release composition |
| FR2752162B1 (fr) * | 1996-08-07 | 1998-11-06 | Jouveinal Lab | Comprime de maleate de trimebutine pellicule |
| US5780055A (en) | 1996-09-06 | 1998-07-14 | University Of Maryland, Baltimore | Cushioning beads and tablet comprising the same capable of forming a suspension |
| US5807580A (en) | 1996-10-30 | 1998-09-15 | Mcneil-Ppc, Inc. | Film coated tablet compositions having enhanced disintegration characteristics |
| US5837379A (en) | 1997-01-31 | 1998-11-17 | Andrx Pharmaceuticals, Inc. | Once daily pharmaceutical tablet having a unitary core |
| US5751524A (en) * | 1997-03-10 | 1998-05-12 | Square D Company | Ground fault protection circuit for a multiple source system |
| US6210710B1 (en) | 1997-04-28 | 2001-04-03 | Hercules Incorporated | Sustained release polymer blend for pharmaceutical applications |
| WO1999015172A1 (de) * | 1997-09-25 | 1999-04-01 | Bayer Aktiengesellschaft | Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung |
| TW477702B (en) | 1997-10-23 | 2002-03-01 | Dev Center Biotechnology | Controlled release tacrine dosage form |
| US6156347A (en) | 1998-01-21 | 2000-12-05 | Bio-Dar Ltd. | Controlled release chromium picolinate |
| US6251430B1 (en) | 1998-02-04 | 2001-06-26 | Guohua Zhang | Water insoluble polymer based sustained release formulation |
-
2002
- 2002-04-12 US US10/120,501 patent/US7125563B2/en not_active Expired - Fee Related
-
2003
- 2003-04-11 HR HR20040945A patent/HRP20040945A2/hr not_active Application Discontinuation
- 2003-04-11 WO PCT/US2003/009210 patent/WO2003086364A1/en not_active Ceased
- 2003-04-11 RU RU2004133532/15A patent/RU2004133532A/ru not_active Application Discontinuation
- 2003-04-11 AU AU2003218397A patent/AU2003218397A1/en not_active Abandoned
- 2003-04-11 JP JP2003583385A patent/JP2005532289A/ja active Pending
- 2003-04-11 PL PL03373328A patent/PL373328A1/xx not_active Application Discontinuation
- 2003-04-11 EP EP03714395A patent/EP1494653A1/en not_active Withdrawn
- 2003-04-11 CA CA002481667A patent/CA2481667A1/en not_active Abandoned
- 2003-04-11 CN CNA038115018A patent/CN1655765A/zh active Pending
-
2006
- 2006-01-17 US US11/332,158 patent/US20060105037A1/en not_active Abandoned
-
2008
- 2008-01-09 US US11/971,741 patent/US20080107730A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20100682T1 (hr) | Formulacija tablete produljenog oslobadanja koja sadrzi pramipeksol ili njegovu farmaceutski prihvatljivu sol, postupak njezine priprave i uporaba | |
| JP2008503475A5 (enExample) | ||
| JP2005529870A5 (enExample) | ||
| WO2003000237A8 (en) | Biodegradable polymer coompositions | |
| JP2003292804A5 (enExample) | ||
| CA2433032A1 (en) | Sustained release drug delivery devices with coated drug cores | |
| JP2005247999A5 (enExample) | ||
| WO2004056337A3 (en) | Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats | |
| JP2009545560A5 (enExample) | ||
| DK1183014T3 (da) | Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse | |
| JP2002532112A5 (enExample) | ||
| ATE303793T1 (de) | Pharmazeutische komposition für verlängerte/langanhaltende freisetzung eines therapeutisch aktiven wirkstoffes | |
| IL149573A0 (en) | Multi-layer preparation in film form, consisting of hydrophilic polymers, for the rapid release of active ingredients | |
| JP2004525194A5 (enExample) | ||
| JP2007505773A5 (enExample) | ||
| WO1998029095A3 (en) | Sustained release cisapride mini-tablet formulation | |
| UA94917C2 (ru) | Композиции для местного применения | |
| JP2003510400A5 (enExample) | ||
| JP2008509724A5 (enExample) | ||
| NL1016942A1 (nl) | Organisch antireflecterend deklaagpolymeer en bereiding hiervan. | |
| JP2006517543A5 (enExample) | ||
| CA2417887A1 (en) | Particulate composition of eletriptan | |
| JP2004521897A5 (enExample) | ||
| JP2005526061A5 (enExample) | ||
| JP2009019158A5 (enExample) |